论文部分内容阅读
自1992年2月至1993年1月,我科应用我院基因工程室生产的牛源性肝细胞生长因子治疗肝病50例,现将治疗情况报告如下。 一、临床资料 治疗组:50例,其中男40例,女10例,年龄13～68岁。本组50例中急性病毒性肝炎30例,慢性肝炎10例,肝硬化4例,重症肝炎6例(亚重肝1例,慢重肝5例)。 对照组,55例,其中男44例,女11例,年龄12～52岁。55例中急性病毒性肝炎38例,慢性肝炎17例。
From February 1992 to January 1993, our department applied gene engineering department of our hospital bovine derived hepatocyte growth factor in the treatment of liver disease in 50 cases, the treatment is now reported as follows. First, the clinical data Treatment group: 50 cases, 40 males and 10 females, aged 13 to 68 years. The group of 50 patients with acute viral hepatitis in 30 cases, 10 cases of chronic hepatitis, cirrhosis in 4 cases, 6 cases of severe hepatitis (sub-heavy liver in 1 case, 5 cases of chronic severe hepatitis). Control group, 55 cases, including 44 males and 11 females, aged 12 to 52 years. 55 cases of acute viral hepatitis in 38 cases, 17 cases of chronic hepatitis.